Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Cervical Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Sarcoma

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Biliary Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Penile Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Vaginal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Gastric Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Colon Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Vulvar Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation (849-001)

  • Details

ClinicalTrials.gov ID: NCT03785249
Diagnosis Type: NA
USOR Number: 19151

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

RESILIENT: A Randomized, Open Label Phase 3 Study of Irinotecan Liposome Injection (ONIVYDE®) versus Topotecan in Patients with Small Cell Lung Cancer Who Have Progressed on or after Platinum-based First-Line Therapy (MM-398-01-03-04)

  • Details

ClinicalTrials.gov ID: NCT03088813
Diagnosis Type: NA
USOR Number: 17099

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

Clovis CO-338-087/GOG-3020/ENGOT-ov45/NCRI/ATHENA: A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03522246
Diagnosis Type: NA
USOR Number: 17182

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Fallopian Tube Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

Clovis CO-338-087/GOG-3020/ENGOT-ov45/NCRI/ATHENA: A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03522246
Diagnosis Type: NA
USOR Number: 17182

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

Clovis CO-338-087/GOG-3020/ENGOT-ov45/NCRI/ATHENA: A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03522246
Diagnosis Type: NA
USOR Number: 17182

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)

  • Details

ClinicalTrials.gov ID: NCT04083976
Diagnosis Type: NA
USOR Number: 19092

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

(MO40597) A MULTICENTRIC, OPEN-LABEL, SINGLE ARM STUDY OF OBINUTUZUMAB SHORT DURATION INFUSION (SDI) IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA (PHASE IV STUDY)

  • Details

ClinicalTrials.gov ID: NCT03817853
Diagnosis Type: NA
USOR Number: 18265

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Littleton

QBGJ398-302: Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF302)

  • Details

ClinicalTrials.gov ID: NCT04197986
Diagnosis Type: NA
USOR Number: 19094

  • Practice Details

22 W Dry Creek Circle
Littleton, Colorado 80120
42.09 mi. away
P: (303) 730-4700

More Details View Practice Page

Pages